Teladoc Health (NYSE:TDOC) Issues Quarterly Earnings Results, Misses Estimates By $0.07 EPS

Teladoc Health (NYSE:TDOC) issued its quarterly earnings data on Wednesday. The health services provider reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.07), Zacks reports. The business had revenue of $640.49 million for the quarter, compared to the consensus estimate of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. Teladoc Health updated its Q1 2025 guidance to -0.400–0.150 EPS and its FY 2025 guidance to -1.100–0.500 EPS.

Teladoc Health Stock Performance

Shares of TDOC traded down $1.26 during midday trading on Thursday, reaching $9.73. 13,582,969 shares of the stock were exchanged, compared to its average volume of 8,172,402. Teladoc Health has a twelve month low of $6.76 and a twelve month high of $15.95. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The company has a market cap of $1.68 billion, a P/E ratio of -1.69 and a beta of 1.04. The stock’s 50 day simple moving average is $10.61 and its 200 day simple moving average is $9.53.

Wall Street Analyst Weigh In

TDOC has been the topic of a number of recent analyst reports. Bank of America lifted their price target on shares of Teladoc Health from $11.50 to $13.50 and gave the company a “neutral” rating in a research report on Wednesday, February 12th. Needham & Company LLC reiterated a “hold” rating on shares of Teladoc Health in a research note on Thursday. Barclays boosted their target price on shares of Teladoc Health from $10.00 to $12.00 and gave the company an “overweight” rating in a research note on Thursday, October 31st. Piper Sandler reduced their target price on shares of Teladoc Health from $13.00 to $12.00 and set an “overweight” rating on the stock in a research note on Thursday. Finally, Deutsche Bank Aktiengesellschaft upped their price target on shares of Teladoc Health from $10.00 to $12.00 and gave the stock a “hold” rating in a research report on Friday, November 1st. Eleven research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $11.44.

Insider Transactions at Teladoc Health

In other Teladoc Health news, insider Carlos Nueno sold 2,389 shares of Teladoc Health stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $11.93, for a total value of $28,500.77. Following the transaction, the insider now owns 2,890 shares in the company, valued at $34,477.70. The trade was a 45.25 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 0.95% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.